06.09.2023 17:40:00
|
NEURONES: 8.1% net profit in 1st half 2023
PRESS INFORMATION
Heading: 1st half 2023 results Nanterre, September 6, 2023 (after trading)
8.1% net profit in 1st half 2023
Financial statements as at June 30 (audited in € millions) | H1 2022 | 2022 | H1 2023 |
Revenues | 327.1 | 665.4 | 368.7 |
Business operating profit* | 38.4 (11.7%) | 77 (11.6%) | 41.8 (11.3%) |
Operating profit | 37 (11.3%) | 72.9 (11%) | 39.5 (10.7%) |
Net financial profit | (0.3) | 0 | 1.9 |
Tax on earnings | (10.9) | (21.1) | (11.4) |
Net profit after tax | 25.8 (7.9%) | 51.8 (7.8%) | 30 (8.1%) |
of which, group share | 22.1 | 44.3 | 25.4 |
Staff at end of period | 6,047 | 6,406 | 6,580 |
* before cost of bonus shares.
Achievements
At the end of the first half of the year and after auditing:
- operating profit confirmed at 10.7% of revenues;
- net profit rose sharply (+16.3%) to €30 million;
- net cash (excluding IFRS 16 lease liabilities) increased significantly (€261.3m vs. €232.2m the previous year).
Outlook
NEURONES confirms its forecasts for the year as a whole:
- revenues of more than €730 million,
- operating profit of around 10%.
About NEURONES
With 6,600 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.
Euronext Paris (compartment B - NRO) - Euronext Tech Leaders - DSS mid-caps
www.neurones.net
Press Relations: O'Connection Valérie Hackenheimer Tel.: +33 (0)6 12 80 35 20 vhackenheimer@oconnection.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor Relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
Attachment
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu NeuronesAct.mehr Analysen
Aktien in diesem Artikel
NeuronesAct. | 44,25 | -0,34% |